Latest News & Updates in Child Neurology Nursing
April 16, 2026
Workforce Development & Pipeline Expansion
Efforts to strengthen the child neurology workforce are gaining momentum, with increased focus on early exposure and training pathways for future clinicians. New initiatives emphasize integrating neurology earlier into medical and advanced practice education to address ongoing workforce shortages.
Why it matters for ACNN:
This creates opportunities for nurse practitioners and nurses to play a larger role in education, mentorship, and interdisciplinary training models.
Innovations Shaping Neurology Practice
Experts highlight artificial intelligence, precision medicine, and emerging disease-modifying therapies as key drivers transforming neurologic care in 2026. These innovations are expected to enhance diagnostics, personalize treatment, and improve long-term outcomes.
Clinical impact:
- AI-supported diagnostics and monitoring
- Expansion of targeted therapies
- Greater emphasis on individualized care plans
Advocacy & Policy Progress
Recent advocacy efforts have led to early legislative and policy advancements supporting child neurology priorities, including workforce support and improved access to care.
Advocacy Update: Early Wins for Child Neurology in Congress - Child Neurology Society
Implications:
- Increased national visibility of pediatric neurologic conditions
- Opportunities for nursing leadership in advocacy initiatives
Autism & ADHD May Share Common Brain Biology New research from the Child Mind Institute suggests that autism spectrum disorder (ASD) and ADHD may share overlapping biologic mechanisms that extend beyond traditional diagnostic categories. Investigators found that autism symptom severity—not diagnostic label alone—correlated with distinct patterns of brain connectivity and gene-expression activity in children with either ASD or ADHD. Why This Matters These findings support a growing “transdiagnostic” approach in pediatric neurodevelopment, where symptom dimensions and neural circuitry may be more informative than categorical diagnoses alone. References Molecular Psychiatry Di Martino, A., et al. (2026). Shared neural connectivity patterns across ASD and ADHD. Molecular Psychiatry. Infant Sleep Emerging as a Neurodevelopmental Biomarker A recent review in Pediatric Research highlights the close relationship between infant sleep architecture and early brain development. Researchers identified sleep spindle maturation and EEG organization as potential biomarkers for later neurodevelopmental outcomes. Why This Matters The first year of life represents a critical period of synaptic development and neural maturation. Sleep quality may directly influence: Memory consolidation Cognitive development Emotional regulation Neuroplasticity References O’Connor, C., Ventura, S., Proietti, J. et al. Sleep and infant development in the first year. Pediatr Res (2026). https://doi.org/10.1038/s41390-026-04780-4 Nature Reviews Neuroscience Frank, M. G. (2011). Sleep and synaptic plasticity in the developing brain. Nature Reviews Neuroscience, 12, 477–488. Sleep Medicine Reviews Jan, J. E., et al. (2010). Sleep hygiene for children with neurodevelopmental disabilities. Sleep Medicine Reviews, 14(6), 389–396. Practical Neurology Sheldon, S. H. (2019). Sleep & neurodevelopment. Practical Neurology. Adolescent Brain Development & Psychiatric Risk A longitudinal neuroimaging study found that children with elevated genetic risk for schizophrenia demonstrate reduced frontal cortical surface expansion during early adolescence compared with low-risk peers. Why This Matters The findings provide evidence that neurodevelopmental divergence may begin years before clinical psychiatric symptoms emerge. References Genetic Susceptibility to Schizophrenia and the Onset of Brain Developmental Change in Adolescence ” by Bing Xu, Annet Dijkzeul, Yingzhe Zhang, Isabel K. Schuurmans, Charlotte A.M. Cecil, Phil H. Lee, Ryan L. Muetzel, and Henning Tiemeier. Biological Psychiatry DOI:10.1016/j.biopsych.2026.03.989 Biological Psychiatry Shaw, P., et al. (2007). Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proceedings of the National Academy of Sciences , 104(49), 19649–19654. Lancet Psychiatry Paus, T., et al. (2008). Why do many psychiatric disorders emerge during adolescence? Lancet Psychiatry. Early Screen Exposure & Long-Term Brain Outcomes Longitudinal studies continue to associate excessive screen exposure before age two with altered brain network maturation, increased anxiety symptoms, and reduced cognitive flexibility later in childhood and adolescence. Why This Matters Early sensory environments shape cortical development during periods of heightened neuroplasticity. References Neurobehavioural Links from Infant Screen Time to Anxiety ” by Huang Pei et al. EBioMedicine Pediatrics Madigan, S., et al. (2019). Association between screen time and children’s performance on developmental screening tests. Pediatrics, 143(4). JAMA Pediatrics Hutton, J. S., et al. (2020). Associations between screen-based media use and brain white matter integrity. JAMA Pediatrics, 174(1), e193869.
This month's pediatric neuroscience developments highlight major advances in early autism detection, pediatric attention research, neurodevelopmental genetics, infant brain maturation, and systems-based pediatric neurology care . These findings reinforce the growing role of precision medicine and early intervention in child neurology. Early Autism Detection Through Wearable Technology Researchers at UCLA Health are developing wearable sensor technology capable of detecting subtle motor abnormalities in infants at high risk for autism spectrum disorder (ASD). The study uses wrist- and ankle-based sensors combined with machine learning algorithms to identify movement variability before traditional behavioral symptoms emerge. Why This Matters Motor differences often precede language and social communication changes in ASD. Earlier identification could allow intervention during critical neurodevelopmental windows when neuroplasticity is greatest. Clinical Implications for Pediatric Neuroscience Nurses Increased emphasis on developmental surveillance during infancy Potential integration of digital biomarkers into pediatric neurology clinics Expanded family education regarding early motor signs of ASD References Nature Reviews Neurology Lord, C., et al. (2020). Autism spectrum disorder. Nature Reviews Disease Primers, 6, 5. JAMA Pediatrics Landa, R. J., et al. (2013). Developmental trajectories in infants with autism spectrum disorders. JAMA Pediatrics, 167(7), 629–638. Brain Signals May Predict Attention Lapses in Children A newly identified neural “attention signature” may predict lapses in attention before they occur in children. Investigators demonstrated that real-time recognition of this brain signal could restore focus using targeted interventions. Why This Matters This research may have implications for: ADHD diagnostics Pediatric cognitive rehabilitation Neurofeedback interventions Classroom attention monitoring technologies Clinical Implications Future development of individualized neurocognitive therapies Potential non-pharmacologic interventions for attention disorders Improved objective biomarkers for pediatric attentional dysfunction References Neuron Posner, M. I., & Petersen, S. E. (1990). The attention system of the human brain. Neuron, 13(1), 25–42. Biological Psychiatry Castellanos, F. X., & Proal, E. (2012). Large-scale brain systems in ADHD. Biological Psychiatry, 72(3), 192–197. Infant Sleep Emerging as a Neurodevelopmental Biomarker A new review in Pediatric Research emphasizes the critical relationship between infant sleep architecture and early brain development. Researchers highlight sleep spindle maturation as a potential biomarker for neurodevelopmental outcomes. Why This Matters Sleep quality and organization during infancy may influence: Cognitive development Memory consolidation Synaptic maturation Long-term neurodevelopmental outcomes Clinical Implications Reinforces importance of sleep assessment in developmental evaluations Supports parent education on sleep hygiene May influence NICU and infant follow-up practices References Sleep Medicine Reviews Jan, J. E., et al. (2010). Sleep hygiene for children with neurodevelopmental disabilities. Sleep Medicine Reviews, 14(6), 389–396. Nature Reviews Neuroscience Frank, M. G. (2011). Sleep and synaptic plasticity in the developing brain. Nature Reviews Neuroscience, 12, 477–488. New Genetic Insights Into Neurodevelopmental Disorders Researchers from Baylor College of Medicine and Texas Children’s Hospital identified a gene-disease association involving ASTN1, a gene critical for neuronal migration and cortical development. Why This Matters The findings help explain previously undiagnosed neurodevelopmental syndromes and reinforce the role of genetic sequencing in pediatric neurology. Clinical Implications Expanding role of neurogenetics in diagnostic evaluation Increased importance of interdisciplinary genetic counseling Potential future precision therapies targeting neuronal migration pathways References Lancet Neurology Guerrini, R., & Dobyns, W. B. (2014). Malformations of cortical development. Lancet Neurology, 13(7), 710–726. Neuron Valiente, M., & Marín, O. (2010). Neuronal migration mechanisms. Neuron, 66(4), 573–587. Early Screen Exposure & Adolescent Brain Outcomes Longitudinal data continue to show associations between excessive screen exposure before age two and later anxiety symptoms, altered cognitive flexibility, and changes in brain network maturation. Why This Matters This reinforces concerns surrounding early digital exposure during sensitive neurodevelopmental periods. Clinical Implications Strengthens anticipatory guidance recommendations for families Encourages developmental counseling around media exposure Supports integration of environmental history into pediatric assessments References Pediatrics Madigan, S., et al. (2019). Association between screen time and children’s performance on developmental screening tests. Pediatrics, 143(4). JAMA Pediatrics Hutton, J. S., et al. (2020). Associations between screen-based media use and brain white matter integrity. JAMA Pediatrics, 174(1), e193869. Stoke Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Updates Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development with Biogen (Nasdaq: BIIB) as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today reported financial results for the first quarter ended March 31, 2026, and announced new 4-year longitudinal data from the ongoing Phase 1/2a open-label extension (OLE) studies that provide additional support for zorevunersen as a potential disease-modifying treatment for Dravet syndrome. Statistically significant improvements were demonstrated in cognition and behavior at 1, 2, 3 and 4 years of treatment compared to OLE baseline. Reductions in major motor seizure frequency were observed through 4 years of treatment in patients taking standard anti-seizure medicines (ASMs). Zorevunersen continues to be generally well tolerated, with some patients treated for more than 5 years in the Phase 1/2a and ongoing OLE studies. The Company also announced an update on progress of the global Phase 3 EMPEROR study. Enrollment of approximately 150 patients in the U.S., UK and Japan is expected to complete in June 2026 to support a data readout in mid-2027. These data are anticipated to complete the rolling New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) planned to initiate in the first quarter of 2027. Read the full press release here: https://investor.stoketherapeutics.com/news-releases/news-release-details/stoke-therapeutics-announces-first-quarter-2026-financial
The neuroscience landscape continues to evolve at an accelerated pace, with innovations in neurotechnology, neurodegenerative disease, and neurodevelopment shaping the future of patient care. This week's highlights emphasize the growing role of precision medicine, brain–body connections, and translational science in clinical practice. Brain Signals & Neurophysiology New research from Northwestern Medicine provides deeper insight into how high-gamma brain activity—a key signal used in EEG and intracranial monitoring—is generated at the cellular level. These findings may refine how we interpret neural activity in epilepsy, cognition, and BCI applications. High-frequency activity has long been associated with cortical processing, but this work suggests more precise cellular drivers , potentially improving diagnostic accuracy in neurophysiology. Northwestern Medicine. (2026). High gamma activity and neural signaling. Neuro-oncology: Brain–Tumor Interactions A new study shows that certain non-neuronal brain cells actively promote glioblastoma growth through signaling pathways previously thought to be supportive only of normal brain function. Blocking these signals significantly reduced tumor progression in models. This aligns with growing literature on the tumor microenvironment , emphasizing neuron–glia–tumor interactions as therapeutic targets. Venkataramani, V., et al. (2026). Neuron–glioma interactions in tumor progression. Neuroplasticity & Regeneration Research published in Current Biology highlights how “tunneling neurons” in songbirds enable ongoing neurogenesis in adulthood. This mechanism may explain why humans have limited regenerative capacity—and how it might be therapeutically induced. These findings contribute to regenerative neuroscience, suggesting a trade-off between memory stability and neuronal renewal . Scott, B., et al. (2026). Neurogenesis via tunneling neurons. Current Biology. Brain Development & Big Data Neuroscience A major multi-omics database integrating data from 188 studies has mapped human neocortical development at unprecedented resolution , improving understanding of how the brain develops layer-by-layer and cell-by-cell. Large-scale datasets are accelerating precision neurodevelopmental modeling , with implications for congenital disorders and pediatric neurology. University of Maryland School of Medicine. (2026). Neocortical development database. Neurodegeneration: Expanding Disease Models Emerging evidence suggests that some motor symptoms in Alzheimer’s disease may originate outside the brain , challenging traditional CNS-only models of neurodegeneration. In parallel, new work indicates that gut microbiota may contribute to ALS and frontotemporal dementia through immune-mediated pathways. UCF Research. (2026). Peripheral origins of Alzheimer’s motor symptoms. ScienceDaily. (2026). Gut microbiome in ALS/FTD. Fundamental Neuroscience: Epigenomics & Brain Identity New data in Nature Neuroscience reveal epigenomic signatures in adult glial cells that resemble developmental states, suggesting roles in regeneration and disease processes. Dere, E. (2026). Mental time travel and cognition. Psychological Review. Kabbe, et al. (2026). Epigenomic profiling of CNS cells. Nature Neuroscience. Autism & Neurodevelopment Advances A new research initiative is exploring targeted autism therapies, focusing on underlying biology rather than symptom management. This reflects a broader shift toward mechanism-based treatments in neurodevelopmental disorders. MUSC researchers hope to develop autism treatment | MUSC